Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|261-269

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 261-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First‐line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate‐to‐severe bullous pemphigoid

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 302-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Myth: glucagon is an effective first-line therapy for esophageal foreign body impaction

By  

Canadian Journal of Emergency Medicine, Vol. 11, Iss. 2, 2009-03 ,pp. : 169-171

Cambridge University Press

Access to resources Recommend Favorite

Membranous Nephropathy: An Overview

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 23, Iss. 12, 1975-12 ,pp. : 535-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Second-Line Enuretic Alarm Therapy after Unsuccessful Pharmacotherapy Superior to First-Line Therapy in the Treatment of Monosymptomatic Nocturnal Enuresis?

By  

Urologia Internationalis, Vol. 78, Iss. 3, 2007-04 ,pp. : 260-263

Karger

Access to resources Recommend Favorite